CFC Albuterol To Be Pulled In 2008; FDA Says HFA Makers Need Ramp-Up Time
Executive Summary
FDA is basing its Dec. 31, 2008 deadline for the withdrawal of CFC-containing albuterol on the concern that manufacturers will need additional time to ramp-up production of hydrofluoroalkane products
You may also be interested in...
FDA Proposes Elimination of Seven Metered-Dose Inhaler Compounds
FDA is proposing that seven drugs used in metered-dose inhalers no longer be considered essential for the treatment of asthma and chronic obstructive pulmonary disease. Without such status, the drugs will no longer be exempt from regulations banning the use of chlorofluorocarbons in aerosol containers and will have to come off the market
FDA Proposes Elimination of Seven Metered-Dose Inhaler Compounds
FDA is proposing that seven drugs used in metered-dose inhalers no longer be considered essential for the treatment of asthma and chronic obstructive pulmonary disease. Without such status, the drugs will no longer be exempt from regulations banning the use of chlorofluorocarbons in aerosol containers and will have to come off the market
Teva/Ivax Merger Will Create Significant Pricing Flexibility In Generics
Teva is prepared to leverage its $7.4 bil. acquisition of Ivax to offer the lowest prices on generic drugs "if need be," Ivax Chairman Phillip Frost said July 26 during a call regarding the deal